Ismaila Olatunji Sule*

^1,2,3Biomedical Scientist & Associate Lecturer

¹Southwest Pathology Services, Microbiology department, SPS Hub Laboratory, Lisieux Way, Taunton, TA1 2LB England.

²Consultant at GOLA5 Biomedical Science Consulting Service 7, Moatview Crescent, BT16 2BG. United Kingdom.

³Associate Lecturer in Infectious Diseases & Public Health, School of Life, Health & Chemical Sciences, The Open University, United Kingdom.

*Corresponding Author: Ismaila Olatunji Sule, Biomedical Scientist & Associate Lecturer, Southwest Pathology Services, Microbiology department, SPS Hub Laboratory, Lisieux Way, Taunton, TA1 2LB England. ORCID ID: https://orcid.org/0000-0001-9710-5084.

Abstract
Antimicrobial resistance (AMR) poses a significant and growing threat to public health globally, with Africa facing challenges due to socioeconomic factors, healthcare infrastructure limitations, and environmental conditions. This abstract examines the current landscape of AMR in Africa, highlighting the continent's epidemiology, contributing factors, and consequences. Despite limited comprehensive data, AMR has emerged as a critical issue, exacerbating the burden of infectious diseases and compromising treatment efficacy. Factors such as inadequate infection control measures, overuse and misuse of antibiotics, and limited access to quality healthcare contribute to the proliferation of resistant pathogens. The consequences are profound, with increasing mortality and morbidity rates from once manageable infections. Efforts to combat AMR in Africa must prioritize strengthened surveillance systems, improved antimicrobial stewardship, enhanced infection prevention and control strategies, and equitable access to effective antimicrobials. Addressing AMR in Africa requires a coordinated effort involving policymakers, healthcare providers, researchers, and communities to mitigate its Impact and safeguard public health in the region.

Introduction
Antimicrobial resistance (AMR) poses a formidable threat to public health and economic stability worldwide [12,19], with its impact particularly pronounced in Africa [3,4,11]. The continent faces a unique series of challenges in managing AMR, stemming from a combination of limited healthcare infrastructure, inadequate surveillance systems, widespread misuse of antibiotics, and significant economic constraints [1,2,12,14,15,19]. These factors, compounded by cultural and behavioural influences, environmental contamination, and political instability, create a complex landscape that hampers effective AMR management [16]. Addressing these issues requires a multifaceted approach involving enhanced healthcare systems, robust regulatory frameworks, comprehensive public education, and significant investments in research and development [4,5].

Addressing these issues requires a multifaceted approach because microorganism resistance patterns between Gram-positive and Gram- negative bacteria are of different types, which might not be controlled and prevented using various methodologies [7]. These include bacteria that cause Methicillin-resistant Staphylococcus aureus (MRSA), Extended Spectrum beta-lactamases (ESBL), carbapenemases-resistant Enterobacteriaceae (CRE), Vancomycin- resistant Enterococcus (VRE), and drug-resistant tuberculosis (TB) [2,5,7]. Combating AMR in Africa is urgent because it has the potential to undermine decades of progress in health outcomes and exacerbate existing health disparities. Therefore, a coordinated and sustained effort involving national governments, international organizations, healthcare providers, and communities is crucial to safeguarding the health of current and future generations.

Materials and Methods
This study employs a comprehensive review methodology, analysing data from peer-reviewed journals, government reports, and international health organization databases. The review focuses on the prevalence and trends of AMR in Africa, identifying key resistant pathogens and evaluating the effectiveness of existing management strategies. In addition, we gathered qualitative data through interviews with healthcare professionals and policymakers from various African countries. These interviews provided insights into AMR management efforts' practical challenges and successes.

Prevalence and Trends of AMR in Africa
The review revealed a high prevalence of AMR across the continent, with significant variations between regions [10,18]. Common resistant pathogens include methicillin-resistant Staphylococcus aureus  (MRSA),  multidrug-resistant  tuberculosis  (MDR-TB), extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae, Carbapenemases- resistant   Enterobacteriaceae (CRE), and Vancomycin-resistant Enterococcus (VRE) [5,6,7,8,9]. Factors contributing to high AMR rates include over-the-counter sales of antibiotics without prescriptions [12], lack of public awareness about the dangers of antibiotic misuse [13], insufficient infection control practices in healthcare facilities [2], lack of effective surveillance systems [8], inadequate regulation and policy implementation [5], limited research and development, Impact of infectious diseases [10], and environmental factors [11,17]. Addressing these challenges requires a coordinated and comprehensive approach that involves strengthening healthcare providers/systems, improving surveillance, fostering research and development, implementing effective regulations, and raising public awareness [7,8,13]. Only through such multifaceted efforts can the Impact of AMR in Africa be mitigated, safeguarding public health for future generations.

Strategies for Managing AMR
Addressing antimicrobial resistance (AMR) in Africa requires a multifaceted and collaborative approach, integrating efforts from various sectors and stakeholders. However, government and stakeholders implemented several strategies to combat AMR in Africa, including:

Antibiotic Stewardship Programs is an initiative to promote the rational use of antibiotics among healthcare providers, and the public must be encouraged [3,14,17]. The government and stakeholders must develop training programs to educate people on appropriate antibiotic-prescribing practices [3]. The government is strengthening healthcare systems by improving healthcare infrastructure, including better diagnostic facilities to identify infections and guide treatment accurately [5,15] and enhancing surveillance and monitoring by establishing surveillance systems to monitor AMR trends and track the spread of resistant pathogens.

Regional networks, such as the African CDC’s Antimicrobial Resistance Surveillance Network, play a crucial role [1,8,15]. Notably, the government and stakeholders should implement policies to regulate the sale and distribution of antibiotics, thereby reducing over-the-counter availability without prescriptions [5,13,17]. Public awareness campaigns and education initiatives raise awareness about AMR among the general public, emphasizing the importance of completing prescribed antibiotic courses and only using antibiotics with medical advice [9,15,18].

The essential aspect of enhancing Infection Prevention and Control (IPC) is to limit the spread of resistant organisms. This includes regular training for healthcare staff on hygiene practices, the use of protective equipment, and effective IPC strategies. The government must ensure that healthcare facilities are adequately supplied with essential IPC materials, such as gloves, disinfectants, and sterile equipment. This is crucial for maintaining high infection control standards and preventing healthcare-associated infections [15,17].

Challenges in AMR Management in Africa
Despite the above-mentioned strategies to reduce AMR, several challenges hinder the effective management of AMR in Africa, which must be highlighted here. Managing antimicrobial resistance (AMR) in Africa is hindered by various complex challenges that require a comprehensive and coordinated approach. One of the primary obstacles is the need for more healthcare infrastructure. Many regions need more healthcare facilities, equipment, and trained personnel, making implementing effective infection control measures difficult. The need for healthcare facilities is compounded by inconsistent implementation of these measures due to resource constraints [16,17]. Inadequate surveillance systems present another significant challenge. While progress has been made, robust, coordinated systems need to be improved in tracking antibiotic use and resistance patterns. This results in insufficient data to inform policy and practice, hampering efforts to monitor and respond to AMR effectively.

The widespread availability of over-the-counter antibiotics exacerbates the problem. Easy access to antibiotics without prescriptions leads to self-medication and misuse, which are significant contributors to the development of resistance [16,17,18]. Weak regulatory frameworks further complicate the situation, as inconsistent and poorly enforced regulations on antibiotic use make it difficult to control misuse in both healthcare and agricultural settings. Public awareness and education about AMR could be higher [5]. There needs to be more understanding about the dangers of AMR and the importance of responsible antibiotic use. Misunderstandings and cultural beliefs also influence how antibiotics are used, often leading to inappropriate practices. Economic constraints are a significant barrier to effective AMR management [19]. Limited research, prevention, and control funding hampers efforts to address the issue. Financial barriers also prevent many people from accessing proper healthcare and appropriate antibiotic treatments, leading to further misuse and resistance [13]. Cultural and behavioural factors also play a role. Established practices and beliefs about antibiotics are difficult to change, and healthcare providers often resist altering prescribing habits. These factors contribute to the continued misuse of antibiotics. Environmental factors also pose a challenge; consequently, Poor waste management practices result in antibiotic residues contaminating water and soil, which can spread resistant bacteria. This environmental contamination is a significant but often overlooked contributor to AMR. The extensive use of antibiotics in livestock for growth promotion and disease prevention in the agricultural sector is problematic [12]. Limited regulations and oversight on antibiotic use in agriculture contribute to the spread of resistance from animals to humans. Political instability and conflict further exacerbate the situation. Conflicts cause disruptions in healthcare services and infrastructure, making it difficult to maintain consistent AMR management efforts in affected regions, finally, more research and development related to AMR are needed.

Local research initiatives are limited, and advancements in understanding and managing AMR heavily depend on international support and collaboration [13].

Conclusion
Addressing AMR in Africa requires a coordinated and multifaceted approach involving national governments, international organizations, healthcare providers, and communities. While significant strides have been made, continued efforts are needed to strengthen healthcare systems, improve surveillance, enforce regulatory measures, and enhance public awareness. Collaboration and sustained investment are essential to mitigate the Impact of AMR and safeguard public health across the continent.

Acknowledgments:
I would like to extend my gratitude to the Biomedical Science Consulting Service, GOLA5, Belfast, United Kingdom, for delivering a thorough review of the study.

Conflicts of Interest:
The author declared no potential conflicts of interest concerning this article's research, authorship, and publication.

Funding Information:
The author(s) received no financial support for the research, authorship, and publication of this article.

References

1. African Union. (2018) Africa CDC Antimicrobial Resistance. Surveillance Network (AMRSNET).
2. African Union. (2018) Framework for Antimicrobial Resistance. Control in Africa.
3. Boston University Combating Antimicrobial-Resistant Bacterial. A 4-year antimicrobial stewardship program successfully reduces antibiotic resistance - Carb-X.
4. Centers for Disease Control and Prevention (CDC). (2020) Antibiotic Resistance Threats in the United States.
5. Dar OA, Hasan R, Schlundt J, Harbarth S, Caleo G, et al. (2016) Exploring the evidence base for national and regional policy interventions to combat resistance. The Lancet. 387(10015): 285- 95.
6. Essack SY, Desta AT, Abotsi RE, Agoba EE (2017) Antimicrobial resistance in the WHO African region: current status and roadmap for action. Journal of Public Health. 39(1): 8– 13.
7. WHO (2020) Global Antimicrobial Resistance Surveillance System (GLASS).
8. Heydari G, Zare-Farashbandi F (2015) Knowledge and practice of medical students regarding antibiotic use and resistance in Iran. Journal of Research in Medical Sciences. 19: 518.
9. Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, et al. (2016) Understanding the mechanisms and drivers of antimicrobial resistance. The Lancet. 387(10014): 176-87.
10. Huttner A, Harbarth S, Carlet J, Cosgrove S, Goossens H, et al. (2013) Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrobial Resistance and Infection Control. 2(1): 31.
11. Jonas, Olga B., Irwin, Alec, Berthe, Franck Cesar Jean, Le Gall, Francois G, Marquez, Patricio V. Drug-resistant infections: a threat to our economic future (Vol. 2): final report (English). HNP/Agriculture Global Antimicrobial Resistance Initiative Washington, D.C.: World Bank Group.
12. Mendelson M, Matsoso MP (2015) The World Health Organization Global Action Plan for Antimicrobial Resistance. South African Medical Journal.
13. O'Neill J. (2014) Review on Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations.
14. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, et al. (2007) Antimicrobial resistance in developing countries. Part I: Recent trends and current status. The Lancet Infectious Diseases. 5(8): 481-93.
15. Radyowijati A, Haak H (2003) Improving antibiotic use in low- income countries: an overview of evidence on determinants. Social Science & Medicine. 57(4): 733-44.
16. Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, et al. (2015) The global threat of antimicrobial resistance: science for intervention. New Microbes and New Infections. 6: 22-9.
17. Ventola CL (2015) The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and Therapeutics. 40(4): 277–283.
18. World Bank (2017) Drug-Resistant Infections: A Threat to Our Economic Future.
19. World Health Organization (WHO) (2019) No Time to Wait: Securing the Future from Drug-Resistant Infections.